Download PDF
Am J Perinatol 2023; 40(15): 1715-1724
DOI: 10.1055/s-0041-1740177
Original Article

Neonatal Outcomes of Premature Infants Born to Women with the Novel Coronavirus (SARS-CoV-2) Infection: A Case Control Study

Beril Yasa
1   Neonatology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey
,
Seyma Memur
1   Neonatology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey
,
Dilek Y. Ozturk
1   Neonatology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey
,
Onur Bagci
1   Neonatology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey
,
Sait I. Uslu
1   Neonatology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey
,
Merih Cetinkaya
1   Neonatology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective Novel coronavirus disease 2019 (COVID-19) is a disease associated with atypical pneumonia caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). The first cases of COVID-19 were reported in Wuhan at the end of 2019. Transmission usually occurs via infected droplets and close personal contact; the possibility of vertical transmission is still under debate. This retrospective study aimed to analyze clinical characteristics of premature infants born to mothers with symptomatic COVID-19 disease.

Study Design This case control study compared the clinical and laboratory data of 20 premature infants born to mothers infected with SARS-CoV-2 with sex and gestational age–matched historical controls.

Results The median gestational age and birth weight in both groups were similar. Respiratory distress developed in 11 (55.5%) infants in study group and 19 (47.5%) infants in control group. Mechanical ventilation and endotracheal surfactant administration rates were similar. Median duration of hospitalization was 8.5 (2–76) days in study group and 12 days in historical controls. Real-time reverse-transcription polymerase chain reaction tests (RT-PCR) of nasopharyngeal swab samples for SARS-CoV-2 were found to be negative twice, in the first 24 hours and later at 24 to 48 hours of life. No neutropenia or thrombocytopenia was detected in the study group. Patent ductus arteriosus, bronchopulmonary dysplasia, and necrotizing enterocolitis rates were similar between groups. No mortality was observed in both groups.

Conclusion To the best of our knowledge, this is one of the few studies evaluating the clinical outcomes of premature infants born to SARS-CoV-2 infected mothers. There was no evidence of vertical transmission of SARS-CoV-2 from symptomatic SARS-CoV-2-infected women to the neonate in our cohort. The neonatal outcomes also seem to be favorable with no mortality in preterm infants.

Key Points

  • SARS-CoV-2 pandemic is a challenge for pregnant women.

  • Neonatal outcomes of premature infants born to mothers infected with SARS-CoV-2 not well defined.

  • SARS-CoV-2 infection seems to have no adverse effect on mortality and morbidity in premature infants.

Keywords

SARS-CoV-2 - COVID-19 - premature - newborn

Authors' Contributions

B.Y. and M.C. conceptualized and designed the study, were involved in data acquisition, analysis, and interpretation of data. S.M., D.Y.O., O.B., and S.I.U. were involved in acquisition and analysis of data. B.Y. drafted the article and M.C. finally approved the submitted version.




Publication History

Received: 01 March 2021

Accepted: 12 October 2021

Article published online:
28 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology 2003; 8 (1, suppl): S9-S14
    CrossrefPubMedGoogle Scholar
  • 2 World Health Organization. Middle east respiratory syndrome coronavirus. Accessed May 13, 2020 at: https://www.who.int/emergencies/mers-cov/en/
    PubMedGoogle Scholar
  • 3 Zhou G, Chen S, Chen Z. Back to the spring of 2020: facts and hope of COVID-19 outbreak. Front Med 2020; 14 (02) 113-116
    CrossrefPubMedGoogle Scholar
  • 4 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2020; 382 (08) 727-733
    CrossrefPubMedGoogle Scholar
  • 5 Islam MM, Poly TN, Walther BA. et al. Clinical characteristics and neonatal outcomes of pregnant patients with COVID-19: A systematic review. Front Med (Lausanne) 2020; 7 (07) 573468
    CrossrefPubMedGoogle Scholar
  • 6 Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol 2020; 37 (08) 861-865
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Oncel MY, Akın IM, Kanburoglu MK. et al; Neo-Covid Study Group. A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society. Eur J Pediatr 2021; 180 (03) 733-742
    CrossrefPubMedGoogle Scholar
  • 8 Yu N, Li W, Kang Q. et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis 2020; 20 (05) 559-564
    CrossrefPubMedGoogle Scholar
  • 9 Dhir SK, Kumar J, Meena J, Kumar P. Clinical features and outcome of SARS-CoV-2 infection in neonates: a systematic review. J Trop Pediatr 2021; 67 (03) fmaa059
    CrossrefPubMedGoogle Scholar
  • 10 Smith V, Seo D, Warty R. et al. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review. PLoS One 2020; 15 (06) e0234187
    CrossrefPubMedGoogle Scholar
  • 11 Collins A, Weitkamp JH, Wynn JL. Why are preterm newborns at increased risk of infection?. Arch Dis Child Fetal Neonatal Ed 2018; 103 (04) F391-F394
    CrossrefPubMedGoogle Scholar
  • 12 Fouda GG, Martinez DR, Swamy GK, Permar SR. The Impact of IgG transplacental transfer on early life immunity. Immunohorizons 2018; 2 (01) 14-25
    CrossrefPubMedGoogle Scholar
  • 13 Sharma AA, Jen R, Butler A, Lavoie PM. The developing human preterm neonatal immune system: a case for more research in this area. Clin Immunol 2012; 145 (01) 61-68
    CrossrefPubMedGoogle Scholar
  • 14 Mullins E, Hudak ML, Banerjee J. et al; PAN-COVID investigators and the National Perinatal COVID-19 Registry Study Group. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol 2021; 57 (04) 573-581
    CrossrefPubMedGoogle Scholar
  • 15 Lavizzari A, Klingenberg C, Profit J. et al; International Neonatal COVID-19 Consortium. International comparison of guidelines for managing neonates at the early phase of the SARS-CoV-2 pandemic. Pediatr Res 2021; 89 (04) 940-951
    CrossrefPubMedGoogle Scholar
  • 16 Erdeve Ö, Çetinkaya M, Baş AY. et al. The Turkish Neonatal Society proposal for the management of COVID-19 in the neonatal intensive care unit. Turk Pediatri Ars 2020; 55 (02) 86-92
    PubMedGoogle Scholar
  • 17 Özkan H, Erdeve Ö, Kutman HGK. Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment. Turk Pediatri Ars 2018; 53 (Suppl. 01) S45-S54
    PubMedGoogle Scholar
  • 18 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163 (07) 1723-1729
    Google Scholar
  • 19 Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33 (01) 179-201
    Google Scholar
  • 20 Volpe JJ. Intracranial hemorrhage: germinal matrix–intraventricular hemorrhage of the premature infant. In: Volpe JJ. ed. Neurology of the Newborn. 5th ed.. Philadelphia, PA: Elsevier; 2008: 517-588
    Google Scholar
  • 21 International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123 (07) 991-999
    CrossrefPubMedGoogle Scholar
  • 22 Satar M, Arısoy AE, Çelik IH. Turkish Neonatal Society guideline on neonatal infections-diagnosis and treatment. Turk Pediatri Ars 2018; 53 (Suppl. 01) S88-S100
    CrossrefPubMedGoogle Scholar
  • 23 Kucirka LM, Norton A, Sheffield JS. Severity of COVID-19 in pregnancy: a review of current evidence. Am J Reprod Immunol 2020; 84 (05) e13332
    CrossrefPubMedGoogle Scholar
  • 24 Maheshwari A. Neutropenia in the newborn. Curr Opin Hematol 2014; 21 (01) 43-49
    CrossrefPubMedGoogle Scholar
  • 25 Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003; 88 (05) F359-F364
    CrossrefPubMedGoogle Scholar
  • 26 Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA. et al. Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol 2020; 39 (03) 246-250
    CrossrefPubMedGoogle Scholar
  • 27 De Rose DU, Piersigilli F, Ronchetti MP. et al; Study Group of Neonatal Infectious Diseases of The Italian Society of Neonatology (SIN). Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far. Ital J Pediatr 2020; 46 (01) 56
    CrossrefPubMedGoogle Scholar
  • 28 Schwartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) Coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020; 12 (02) 194
    CrossrefPubMedGoogle Scholar
  • 29 Dashraath P, Wong JLJ, Lim MXK. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020; 222 (06) 521-531
    CrossrefPubMedGoogle Scholar
  • 30 Zheng QL, Duan T, Jin LP. Single-cell RNA expression profiling of ACE2 and AXL in the human maternal–fetal interface. Reprod Dev Med 2020; 4 (01) 7-10
    CrossrefPubMedGoogle Scholar
  • 31 Sánchez-Luna M, Fernández Colomer B, de Alba Romero C. et al; SENEO COVID-19 Registry Study Group. Neonates born to mothers with COVID-19: data from the Spanish Society of Neonatology Registry. Pediatrics 2021; 147 (02) e2020015065
    CrossrefPubMedGoogle Scholar
  • 32 Kotlyar AM, Grechukhina O, Chen A. et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224 (01) 35-53.e3
    CrossrefPubMedGoogle Scholar
  • 33 Salvatore CM, Han JY, Acker KP. et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health 2020; 4 (10) 721-727
    CrossrefPubMedGoogle Scholar
  • 34 Schwartz DA. An analysis of 38 pregnant women with COVI-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020; 144 (07) 799-805
    CrossrefPubMedGoogle Scholar
  • 35 Puopolo KM, Hudak ML, Kimberlein DW, Cummings J. Management of infants born to mothers with COVID-19. American Academy of Pediatrics. Accessed April 7, 2020 at: https://www.tn.gov/content/dam/tn/health/documents/cedep/novel-coronavirus/AAP_COVID-19-Initial-Newborn-Guidance.pdf
    PubMedGoogle Scholar
  • 36 Altendahl M, Afshar Y, de St Maurice A, Fajardo V, Chu A. Perinatal maternal-fetal/neonatal transmission of COVID-19: A guide to safe maternal and neonatal care in the era of COVID-19 and physical distancing. Neoreviews 2020; 21 (12) e783-e794
    CrossrefPubMedGoogle Scholar
  • 37 Centers for Disease Control and Prevention. Evaluation and management considerations for neonates at risk for COVID-19. Accessed August 18, 2020 at: https://www.hsdl.org/?view&did=838625
    PubMedGoogle Scholar
  • 38 Zeng L, Xia S, Yuan W. et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 2020; 174 (07) 722-725
    CrossrefPubMedGoogle Scholar
  • 39 Chen H, Guo J, Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815
    CrossrefPubMedGoogle Scholar
  • 40 Zhu H, Wang L, Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9 (01) 51-60
    CrossrefPubMedGoogle Scholar
  • 41 Bertino E, Moro GE, De Renzi G. et al; Collaborative Research Group on SARS-CoV-2 in Human Milk. Detection of SARS-CoV-2 in milk from COVID-19 positive mothers and follow up of their infants. Front Pediatr 2020; 8: 597699
    CrossrefPubMedGoogle Scholar
  • 42 Li Y, Zhao R, Zheng S. et al. Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis 2020; 26 (06) 1335-1336
    CrossrefPubMedGoogle Scholar
  • 43 Piersigilli F, Carkeek K, Hocq C. et al. COVID-19 in a 26-week preterm neonate. Lancet Child Adolesc Health 2020; 4 (06) 476-478
    CrossrefPubMedGoogle Scholar
  • 44 Groß R, Conzelmann C, Müller JA. et al. Detection of SARS-CoV-2 in human breastmilk. Lancet 2020; 395 (10239): 1757-1758
    CrossrefPubMedGoogle Scholar
  • 45 Bastug A, Hanifehnezhad A, Tayman C. et al. Virolactia in an asymptomatic mother with COVID-19. Breastfeed Med 2020; 15 (08) 488-491
    CrossrefPubMedGoogle Scholar
  • 46 Costa S, Posteraro B, Marchetti S. et al. Excretion of SARS-CoV-2 in human breast milk. Clin Microbiol Infect 2020; 26 (10) 1430-1432
    CrossrefPubMedGoogle Scholar
  • 47 Zhu F, Zozaya C, Zhou Q, De Castro C, Shah PS. SARS-CoV-2 genome and antibodies in breastmilk: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2021; 106 (05) 514-521
    CrossrefPubMedGoogle Scholar
  • 48 Chambers C, Krogstad P, Bertrand K. et al. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA 2020; 324 (13) 1347-1348
    CrossrefPubMedGoogle Scholar
  • 49 Van Keulen BJ, Romijn M, Bondt A. et al. Breastmilk; a source of SARS-CoV-2 specific IgA antibodies. medRxiv 2020; DOI: 10.1101/2020.08.18.20176743.
    CrossrefPubMedGoogle Scholar